12:38 IST
NSE
Earnings Call
OneSource Specialty Pharma Investor Presentation: Key Takeaways
OneSource reported strong Q1 FY27 results with Revenue of INR 4,490M (up 37% YoY) and EBITDA of INR 1,233M (up 39% YoY), driven by semaglutide commercialization and biologics expansion.